Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ikris Pharma Network is an active global pharmaceutical service provider focused on improving healthcare accessibility by supplying unregistered, specialty, and hard-to-access medicines—including those for rare diseases—through named patient import programs. The company operates globally with GDP-compliant warehousing in Belgium and has served over 1200 patients under its access programs. It does not develop proprietary drugs but facilitates compliant sourcing of both branded prescription drugs and generics for patients who have exhausted other treatment options.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ikris Pharma Network.